ストックスクリーナーアプリを入手
130.24
0.73%
1.675
Abbott Laboratories (ABT) 最新ニュース
Abbott Laboratories' (NYSE:ABT) institutional investors lost 4.0% last week but have benefitted from longer-term gains - Yahoo Finance
Abbott Launches India’s First Flexible Tip Catheter To Treat AFib - BW Healthcare World
Abbott Labs Diagnostics Chief Andrea Wainer Strengthens Neogen Board with 25-Year Industry Expertise - Stock Titan
Fund Update: CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM added 2,040,913 shares of ABBOTT LABORATORIES ($ABT) to their portfolio - Nasdaq
Low-Calorie Food Market Top PlayersAbbott Laboratories, - openPR.com
Abbott Laboratories (ABT) Benefitted From Better Execution - MSN
Is Abbott Laboratories' (NYSE:ABT) Latest Stock Performance A Reflection Of Its Financial Health? - Yahoo Finance
Is Wall Street Bullish or Bearish on Abbott Laboratories Stock? - Nasdaq
Fund Update: JENSEN INVESTMENT MANAGEMENT INC added 1,262,407 shares of ABBOTT LABORATORIES ($ABT) to their portfolio - Nasdaq
Law360's Legal Lions Of The Week - Law360
Generic Pharmaceuticals Market Opportunities and Strategy Report 2024-2033 Featuring Key PlayersTeva Pharmaceutical, Sandoz, Sun Pharmaceutical, Viatris, and Abbott LaboratoriesResearchAndMarkets.com - Bluefield Daily Telegraph
The Zacks Analyst Blog Highlights NVIDIA, Abbott Laboratories, Linde and Tredegar - Yahoo Finance
Why Abbott Laboratories (ABT) is Among the Best Medical Device Stocks to Buy Now - Insider Monkey
$9.48 Bn Medical Foods for Inborn Errors of Metabolism Market Opportunities and Strategies to 2034 - GlobeNewswire Inc.
Top Stock Reports for NVIDIA, Abbott Laboratories & Linde - Nasdaq
Is Wall Street Bullish Or Bearish On Abbott Laboratories Stock? - Barchart.com
Abbott Labs Secures Dismissal of Diabetes Supply Fraud Claims - Bloomberg Law News
Reflecting On Medical Devices & SuppliesDiversified Stocks’ Q1 Earnings: Abbott Laboratories (NYSE:ABT) - Yahoo Finance
Abbott Outpaces Peers Defying Tariff Woes: Is ABT Stock a Smart Buy? - Yahoo Finance
Abbott Laboratories (ABT) Continued Sixth Straight Quarter of Double-Digit Gains - Insider Monkey
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Jim Cramer Predicts Big Earnings for Abbott Laboratories (ABT): Libre Leads the Way! - Insider Monkey
Impressive Earnings May Not Tell The Whole Story For Abbott Laboratories (NYSE:ABT) - Yahoo Finance
Abbott’s rapid blood-based concussion test is off to the races - Fierce Biotech
The Zacks Analyst Blog Highlights GE Healthcare, Johnson & Johnson, Abbott and Boston Scientific - Yahoo
Judge throws out case against Abbott over preterm baby formulas - Chicago Tribune
One of Abbott's first federal baby formula lawsuits dismissed - Crain's Chicago Business
Abbott Beats Bellwether Formula MDL Trial in Federal Court Ruling - USA Herald
Judge throws out case against Abbott Laboratories over its preterm baby formula, days before trial was set to begin in Chicago - Yahoo
Positive Legal and Market Factors Justify Buy Rating for Abbott Laboratories - TipRanks
Judge Allows Testimony That Abbott, Mead Johnson Baby Formula Caused Disease - Insurance Journal
Winnetka crash: Raziyeh Sigary, Sediqeh Samadi identified as pedestrians killed at Church Road, Meadow Road; infant injured - ABC7 Chicago
Abbott (ABT) Launches Rapid Concussion Test with MotoAmerica - GuruFocus
Abbott Nutrition Reaches Deal With FDA To Reopen Baby Formula Plant Amid Shortage - Class Action Lawsuits
Abbott Laboratories Director Makes Significant Stock Sale! - TipRanks
Abbott Beats Bellwether In Formula MDL Ahead Of Trial - Law360
US judge allows testimony that Abbott and Mead Johnson preterm baby formula caused deadly disease - Reuters
Abbott Laboratories (ABT) Sees Stock Rise Following Favorable Court Ruling - GuruFocus
Abbott gains after upcoming baby formula case thrown out (ABT:NYSE) - Seeking Alpha
Abbott Laboratories First Quarter 2025 Earnings: EPS Misses Expectations - simplywall.st
Stroke Management Market Is Booming Worldwide | Abbott - openPR.com
Investors in Abbott Laboratories (NYSE:ABT) have seen notable returns of 52% over the past five years - Yahoo Finance
Abbott Laboratories Announces Executive Vice President’s Retirement - TipRanks
Abbott Laboratories (ABT): Among the Best Stocks to Buy During Recession - Insider Monkey
MotoAmerica Becomes First Sports Organization to Use Abbott's Rapid Blood Test for Concussion Evaluation On-site at Races - Yahoo Finance
Abbott Laboratories price tries to shake off negative pressureForecast today01-05-2025 - Economies.com
MotoAmerica: More On Abbott Blood Test for Rapid Concussion Evaluation On-Site - Roadracing World
Abbott Laboratories (ABT): Jim Cramer Calls It a ‘Tour de Force’ — Why He’s Still Amazed at This Stock - Yahoo Finance
Abbott Laboratories (ABT) Announces Results of Annual Shareholders Meeting - GuruFocus
Abbott (ABT) Integrates Libre CGM Data with Epic's Health Records - GuruFocus
Abbott signs deal with Epic for CGM data integration (ABT:NYSE) - Seeking Alpha
0.19%
1.01%
大文字化:
|
ボリューム (24 時間):